A PK-PD Study of PSN821 in Type 2 Diabetes Patients (T2DM)

NCT01386099 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: PSN821
DRUG: Placebo

Sponsor

Prosidion Ltd.